Latest news & insights
Susan Tansey elected as Fellow of the Royal College of Paediatrics and Child Health
We are delighted to share the news that Susan Tansey is being elected as a Fellow of the Royal College of Paediatrics and Child Health
Experienced regulatory professionals join the Boyds team
Boyds is delighted to announce the appointments of Shalini Gupta and Sarah Stevenson to our regulatory team in response to recent growth and the continued
Professor Alan Boyd awarded the Fellowship of the Academy of Medical Sciences
Boyds’ Founder and President, Professor Alan Boyd, has been awarded the Fellowship of the Academy of Medical Sciences. This prestigious award recognises Professor Boyd’s contributions
Boyds supports COVID-19 human infection study
Boyds is working in collaboration with Wellcome on a COVID-19 human infection study which aims to investigate the immunity provided by previous COVID-19 infections to
Opportunities in Clinical Research
One Nucleus recently hosted their Building Life Science Adventures Conference which focused on industry career opportunities, such as clinical research. The two-day event was held
Boyds appoints Neil Chakrabarti as Chief Financial Officer
Boyds is delighted to announce the appointment of Neil Chakrabarti as Chief Financial Officer. The appointment comes as the company reports a record-breaking 25 percent
Supporting the development and regulatory activities for the AstraZeneca-Oxford COVID-19 vaccine
The approval in December for the emergency use of the AstraZeneca-Oxford COVID-19 vaccine by the MHRA provided another key milestone in the response to the
Alan Boyd joins Taysha Gene Therapies’ independent scientific advisory board
Professor Alan Boyd has joined Taysha Gene Therapies’ newly formed independent scientific advisory board. Taysha Gene Therapies, Inc., a patient-centric gene therapy company focused on
